GlaxoSmithKline PLC Director/PDMR Shareholding (7003B)
11 Junio 2021 - 10:55AM
UK Regulatory
TIDMGSK
RNS Number : 7003B
GlaxoSmithKline PLC
11 June 2021
GlaxoSmithKline plc (the ' Company ')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
=== ===============================================================================
a) Name Ms E Walmsley
=== ============================ =================================================
b) Position/status Chief Executive Officer
=== ============================ =================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===============================================================================
a) Name GlaxoSmithKline plc
=== ============================ =================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===============================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ============================ =================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ============================ =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ============== =============================
GBP13.6195 9 (partnership shares)
=== ============================ ============== =============================
GBP13.6195 9 (matching shares)
============== =============================
d) Aggregated information
===
Aggregated volume 18 Ordinary Shares
Price GBP13.6195
=== ============================ =================================================
e) Date of the transaction 2021-06-09
=== ============================ =================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ===============================================================================
a) Name Mr R Connor
=== ============================ =================================================
b) Position/status President, Global Vaccines
=== ============================ =================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===============================================================================
a) Name GlaxoSmithKline plc
=== ============================ =================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===============================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ============================ =================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ============================ =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ============== =============================
GBP13.6195 9 (partnership shares)
=== ============================ ============== =============================
GBP13.6195 9 (matching shares)
============== =============================
d) Aggregated information
===
Aggregated volume 18 Ordinary Shares
Price GBP13.6195
=== ============================ =================================================
e) Date of the transaction 2021-06-09
=== ============================ =================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ===============================================================================
a) Name Ms D Conrad
=== ============================ =================================================
b) Position/status SVP, Human Resources
=== ============================ =================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===============================================================================
a) Name GlaxoSmithKline plc
=== ============================ =================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===============================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ============================ =================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ============================ =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ============== =============================
GBP13.6195 9 (partnership shares)
=== ============================ ============== =============================
GBP13.6195 9 (matching shares)
============== =============================
d) Aggregated information
===
Aggregated volume 18 Ordinary Shares
Price GBP13.6195
=== ============================ =================================================
e) Date of the transaction 2021-06-09
=== ============================ =================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ===============================================================================
a) Name Mr J Ford
=== ============================ =================================================
b) Position/status SVP and General Counsel
=== ============================ =================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===============================================================================
a) Name GlaxoSmithKline plc
=== ============================ =================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===============================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ============================ =================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ============================ =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ============== =============================
GBP13.6195 9 (partnership shares)
=== ============================ ============== =============================
GBP13.6195 9 (matching shares)
============== =============================
d) Aggregated information
===
Aggregated volume 18 Ordinary Shares
Price GBP13.6195
=== ============================ =================================================
e) Date of the transaction 2021-06-09
=== ============================ =================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ===============================================================================
a) Name Mr N Hirons
=== ============================ =================================================
b) Position/status SVP, Global Ethics and Compliance
=== ============================ =================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===============================================================================
a) Name GlaxoSmithKline plc
=== ============================ =================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===============================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ============================ =================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ============================ =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ============== =============================
GBP 13.6195 9 (partnership shares)
=== ============================ ============== =============================
GBP 13.6195 9 (matching shares)
============== =============================
d) Aggregated information
===
Aggregated volume 18 Ordinary Shares
Price GBP 13.6195
=== ============================ =================================================
e) Date of the transaction 2021-06-09
=== ============================ =================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ===============================================================================
a) Name Ms S Jackson
=== ============================ =================================================
b) Position/status SVP, Global Communications and CEO Office
=== ============================ =================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===============================================================================
a) Name GlaxoSmithKline plc
=== ============================ =================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===============================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ============================ =================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ============================ =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ============== =============================
GBP13.6195 9 (partnership shares)
=== ============================ ============== =============================
GBP13.6195 9 (matching shares)
============== =============================
d) Aggregated information
===
Aggregated volume 18 Ordinary Shares
Price GBP13.6195
=== ============================ =================================================
e) Date of the transaction 2021-06-09
=== ============================ =================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ===================================================================================
a) Name Mr D Jackson
=== ============================ =====================================================
b) Position/status PCA of Ms S Jackson (SVP, Global Communications
and CEO Office)
=== ============================ =====================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===================================================================================
a) Name GlaxoSmithKline plc
=== ============================ =====================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ============================ =====================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ============================ =====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ============== =================================
GBP13.6195 10 (partnership shares)
=== ============================ ============== =================================
GBP13.6195 10 (matching shares)
============== =================================
d) Aggregated information
===
Aggregated volume 20 Ordinary Shares
Price GBP13.6195
=== ============================ =====================================================
e) Date of the transaction 2021-06-09
=== ============================ =====================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =====================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ===============================================================================
a) Name Mr D Redfern
=== ============================ =================================================
b) Position/status Chief Strategy Officer
=== ============================ =================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===============================================================================
a) Name GlaxoSmithKline plc
=== ============================ =================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===============================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ============================ =================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ============================ =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ============== =============================
GBP 13.6195 9 (partnership shares)
=== ============================ ============== =============================
GBP 13.6195 9 (matching shares)
============== =============================
d) Aggregated information
===
Aggregated volume 18 Ordinary Shares
Price GBP 13.6195
=== ============================ =================================================
e) Date of the transaction 2021-06-09
=== ============================ =================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ===============================================================================
a) Name Mr R Simard
=== ============================ =================================================
b) Position/status President, Pharmaceuticals Supply Chain
=== ============================ =================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===============================================================================
a) Name GlaxoSmithKline plc
=== ============================ =================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===============================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ============================ =================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ============================ =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ============== =============================
GBP 13.6195 9 (partnership shares)
=== ============================ ============== =============================
GBP 13.6195 9 (matching shares)
============== =============================
d) Aggregated information
===
Aggregated volume 18 Ordinary Shares
Price GBP 13.6195
=== ============================ =================================================
e) Date of the transaction 2021-06-09
=== ============================ =================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ===============================================================================
a) Name Mr P Thomson
=== ============================ =================================================
b) Position/status President, Global Affairs
=== ============================ =================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===============================================================================
a) Name GlaxoSmithKline plc
=== ============================ =================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===============================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ============================ =================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ============================ =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ============== =============================
GBP 13.6195 9 (partnership shares)
=== ============================ ============== =============================
GBP 13.6195 9 (matching shares)
============== =============================
d) Aggregated information
===
Aggregated volume 18 Ordinary Shares
Price GBP 13.6195
=== ============================ =================================================
e) Date of the transaction 2021-06-09
=== ============================ =================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ===============================================================================
a) Name Ms D Waterhouse
=== ============================ =================================================
b) Position/status Chief Executive Officer of ViiV Healthcare
=== ============================ =================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===============================================================================
a) Name GlaxoSmithKline plc
=== ============================ =================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===============================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ============================ =================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ============================ =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ============= ==============================
GBP13.6195 10 (partnership shares)
=== ============================ ============= ==============================
GBP13.6195 10 (matching shares)
============= ==============================
d) Aggregated information
===
Aggregated volume 20 Ordinary Shares
Price GBP13.6195
=== ============================ =================================================
e) Date of the transaction 2021-06-09
=== ============================ =================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ===============================================================================
a) Name Ms V Whyte
=== ============================ =================================================
b) Position/status Company Secretary
=== ============================ =================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===============================================================================
a) Name GlaxoSmithKline plc
=== ============================ =================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===============================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
=== ============================ =================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ============================ =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ============== =============================
GBP 13.6195 9 (partnership shares)
=== ============================ ============== =============================
GBP 13.6195 9 (matching shares)
============== =============================
d) Aggregated information
===
Aggregated volume 18 Ordinary Shares
Price GBP 13.6195
=== ============================ =================================================
e) Date of the transaction 2021-06-09
=== ============================ =================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =================================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHEFLFFFQLEBBB
(END) Dow Jones Newswires
June 11, 2021 11:54 ET (15:54 GMT)
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
